Tech

Isomorphic Labs Valuation Sparks AI Debate

Updated 2026-10-21 18:05 UTC 1 source Neutral

STAT News explores the high valuation of Isomorphic Labs, sparking a debate on AI's role in drug development and its impact on healthcare costs. The article delves into the implications for the tech industry.

Coverage timeline — 1 article

STAT News

STAT+: What’s the deal with Isomorphic Labs?

In this edition of STAT's AI Prognosis: What does Isomorphic Labs' high valuation say about AI's role in drug development, and the debate around AI and cost of care.

2026-10-21 17:49 UTC